Search
Evolent Health Inc
EVHAdd to Watchlist
3.090USD
-0.100-3.14%
Close 07-31 16:00（ET）Quotes delayed by 15 min
347.57MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Evolent Health Inc is 8.13, ranking 66 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 9.75, with a high of 16.00 and a low of 6.00.
Analyst Rating
Based on
15
analysts
Buy
Current Rating
6.596
Target Price
+113.46%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Evolent Health Inc
EVH
15
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Evolent Health Inc's expected revenue for the next quarter?
Evolent Health Inc's expected revenue is 598.00M.
What is Evolent Health Inc's price target?
Analysts forecast that Evolent Health Inc's price target is USD 9.75, with the highest forecast at USD 16.00 and the lowest forecast at USD 6.00.
How have Evolent Health IncEVH's recent earnings per share performed?
The market expectation was USD -0.24, while Evolent Health IncEVH's earnings per share (EPS) for the previous quarter was USD -3.85. EPS for the next quarter is expected at USD -0.02.
What is the analyst rating for Evolent Health Inc?
Based on the ratings of Evolent Health Inc's stock from 15 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.